This inventor holds 2 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 2004-2008.
Location History:
- Kent, GB (2004)
- Dartford, GB (2008)
Company Filing History:
Years Active: 2004-2008
Title: David Colclough: Innovator in Pharmaceutical Chemistry
Introduction
David Colclough is a notable inventor based in Dartford, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications. With a total of 2 patents, Colclough's work has garnered attention in the scientific community.
Latest Patents
One of his latest patents is focused on a nitric oxide synthase inhibitor phosphate salt. This compound, described by the formula (I): namely (2S)-2-amino-4-{[2-(ethanimidoylamino)ethyl]thio}butanoic acid, combined with phosphoric acid, serves as a relatively non-hygroscopic selective inhibitor of inducible nitric oxide synthase. This innovation has potential implications for various medical treatments.
Career Highlights
Colclough is associated with SmithKline Beecham Corporation, where he has been instrumental in advancing research and development in pharmaceutical products. His expertise in chemical processes has contributed to the company's innovative projects.
Collaborations
Throughout his career, Colclough has worked alongside talented colleagues, including Michael Simon Loft and Rebecca Jane Moore. Their collaborative efforts have further enhanced the research output and innovation at their workplace.
Conclusion
David Colclough's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of important therapeutic compounds.